会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • DELIVERY OF BMP-7 AND METHODS OF USE THEREOF
    • BMP-7的递送及其使用方法
    • WO2011043738A3
    • 2011-06-03
    • PCT/SG2010000380
    • 2010-10-06
    • AGENCY SCIENCE TECH & RESZINK DANIELEYING JACKIE YCHOW EDWIN PEI YONGTASNIM FARAH
    • ZINK DANIELEYING JACKIE YCHOW EDWIN PEI YONGTASNIM FARAH
    • A61K38/18
    • A61K38/1875A61M1/3489C12N5/0686C12N2501/155
    • The present invention generally relates to delivery of BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist and methods of use thereof. In some embodiments, methods and devices are provided for delivery of BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist to a patient. In some cases, the BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be released in controlled fashion from a device in fluid communication with a patient. In some embodiments, the BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be expressed by cells within a device. In other embodiments, methods are provided for improving the function of devices containing renal proximal tubule cells. For example, in some embodiments, exposure of renal proximal tubule cells to BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be used to inhibit disruption of cell layers comprising renal proximal tubule cells. In another embodiment, exposure of renal proximal tubule cells to BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be used to inhibit trans- and de-differentiation of renal proximal tubule cells. In another embodiment, exposure of renal proximal tubule cells to BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be used to improve renal proximal tubule cell functions.
    • 本发明一般涉及BMP-7或功能变体或其功能片段和/或BMP-7激动剂的递送及其使用方法。 在一些实施方案中,提供方法和装置用于向患者递送BMP-7或功能变体或其功能性片段和/或BMP-7激动剂。 在一些情况下,BMP-7或其功能变体或功能片段和/或BMP-7激动剂可以以受控的方式从与患者流体连通的装置释放。 在一些实施方案中,BMP-7或其功能变体或功能片段和/或BMP-7激动剂可以由器件内的细胞表达。 在其他实施方案中,提供了用于改善含有肾近端小管细胞的装置功能的方法。 例如,在一些实施方案中,肾近端小管细胞暴露于BMP-7或功能变体或其功能性片段和/或BMP-7激动剂可用于抑制包含肾近端小管细胞的细胞层的破坏。 在另一个实施方案中,肾近端小管细胞暴露于BMP-7或功能变体或其功能片段和/或BMP-7激动剂可用于抑制肾近端小管细胞的反式和去分化。 在另一个实施方案中,肾近端小管细胞暴露于BMP-7或功能变体或其功能片段和/或BMP-7激动剂可用于改善肾近端小管细胞功能。